ICON plc stock reflects solid Q2 2026 revenue and earnings trends as of August 2026, while recent analyst updates frame ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
According to the SEC Form 4 filing, Ronan Martin Murphy, serving as a Director at ICON PLC (NASDAQ:ICLR) ICLR (NASDAQ:ICLR) , ...
The filing indicates that on September 17, 2026, ICON PLC director Eugene Pacelli McCague executed two transactions: first, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...
ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, ...
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company' ...
It has been about a month since the last earnings report for Icon PLC (ICLR). Shares have added about 5.8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results